首页 > 产品展示 > 单克隆抗体
hVimentin FITC
Vimentin expression in human malignant glioma cells depends on cellular density, algorithms of drug delivery and chemo/radio treatment. Vimentin and detyrosinated microtubules provide structural support for the extensive microtentacles observed in detached tumor cells and a mechanism to promote successful metastatic spread. Primary colorectal carcinomas display aberrant expression of vimentin, and have activated Notch and TGFbeta signaling pathways. Vimentin is a strong arterial substrate for transglutaminases. Transglutaminase-mediated vimentin dimerization results in a novel unifying pathway by which vasodilatory and remodeling responses may be regulated. Ablation of vimentin expression inhibits migration and invasion of colon and breast cancer cell lines.
  • Name: hVimentin FITC
  • Synonyms:
  • Catalogue Number:PTAB1450034
  • Application:Immunohistochemistry.
  • Price: 100ug ¥3200.00
  • Number:
  • Concentration:1mg/ml in PBS with 50% Glycerol.
  • Store:-20oC
Cat No.: PTAB1450034
Product Name: hVimentin FITC
Type: Protein
Property:
Origin:
Source: mouse
Application: Immunohistochemistry.
Formulation:
Purity: >95% by SDS-PAGE gel
Storage: Avoid repeated freeze-thaw cycles. 12 months at -20 C to -80 C. 1 month at 2 C to 8 C.
Limitation:
Note: